Kuruvilla Deena E, Tietjen Gretchen E, Panza Gregory A, Hodgkinson Victoria L, Godley Frederick A
Brain Health Institute, Westport, CT, United States.
Department of Neurology, University of Toledo, Toledo, OH, United States.
Front Pain Res (Lausanne). 2025 Aug 21;6:1625442. doi: 10.3389/fpain.2025.1625442. eCollection 2025.
Rhinosinusitis (RS) is a leading reason for antibiotic prescriptions but treatment satisfaction is low. Misdiagnosis may contribute to poor outcomes, as migraine-often underrecognized-can mimic RS symptoms, with studies showing overlap between RS and migraine diagnoses. Our aims were to explore the demographics and clinical features of facial pain or pressure (FPP), its relationship with migraine and RS, and distinguish symptoms between these overlapping conditions.
The HEADS Registry, a web-based survey, targets adults with head and/or neck symptoms. Participants who answered "yes" (FPP+) or "no" (FPP-) to experiencing recurrent facial or sinus pain/pressure were included in this analysis. The ID Migraine screening tool was used to classify participants as ID Migraine+ or ID Migraine-. Demographics, symptoms, disability, history of allergies, sinusitis, and antibiotic use were compared between 1) FPP+ and FPP- groups, 2) FPP+/ ID Migraine+ and FPP+/ID Migraine-, and 3) FPP+/ID Migraine- and FPP-/ID Migraine+ subgroups. Continuous variables were compared using independent samples t-test or Mann-Whitney U, and categorical variables were compared using chi-square or Fisher's exact test.
The FPP+ group ( = 598) was younger, more often female, and reported higher rates of nasal, vestibular, and otologic symptoms compared to the FPP- group ( = 146). They also had more severe headaches, migraine-associated symptoms, and higher ID Migraine screening rates. The FPP+ group reported greater daily symptom interference, and more allergies, sinus infections, and antibiotic use. Those who screened positive for migraine (FPP+/ID Migraine+, = 438) had more severe symptoms, greater disability, and more frequent forehead/eye pain. FPP+/ID Migraine- ( = 48) participants were more likely to report nasal symptoms, allergies, and sinus infections, while FPP-/ID Migraine+ ( = 85) participants reported more disabling headaches.
In this exploratory analysis, FPP was strongly associated with headache, including migraine, as well as allergies, rhinosinusitis, and antibiotic use. The low reported effectiveness of antibiotics suggests potential misdiagnosis. Findings that migraine, plus autonomic, vestibular, otologic symptoms are associated with FPP, highlight the need to expand the differential diagnosis beyond infectious causes. These insights, along with ongoing registry improvements, will support efforts to refine diagnostic accuracy and optimize treatment strategies for neurologic, otologic, and rhinologic conditions.
鼻窦炎(RS)是抗生素处方的主要原因,但治疗满意度较低。误诊可能导致不良后果,因为偏头痛(常未被充分认识)可模仿RS症状,研究表明RS与偏头痛诊断之间存在重叠。我们的目的是探讨面部疼痛或压痛(FPP)的人口统计学和临床特征、其与偏头痛和RS的关系,并区分这些重叠病症之间的症状。
HEADS登记处是一项基于网络的调查,针对有头部和/或颈部症状的成年人。对复发性面部或鼻窦疼痛/压痛回答“是”(FPP+)或“否”(FPP-)的参与者纳入本分析。使用ID偏头痛筛查工具将参与者分类为ID偏头痛+或ID偏头痛-。在以下三组之间比较人口统计学、症状、残疾情况、过敏史、鼻窦炎和抗生素使用情况:1)FPP+组和FPP-组;2)FPP+/ID偏头痛+组和FPP+/ID偏头痛-组;3)FPP+/ID偏头痛-组和FPP-/ID偏头痛+亚组。连续变量使用独立样本t检验或曼-惠特尼U检验进行比较,分类变量使用卡方检验或费舍尔精确检验进行比较。
FPP+组(n = 598)比FPP-组(n = 146)更年轻,女性更多,且报告的鼻部、前庭和耳部症状发生率更高。他们还患有更严重的头痛、偏头痛相关症状以及更高的ID偏头痛筛查率。FPP+组报告的日常症状干扰更大,过敏、鼻窦感染和抗生素使用更多。偏头痛筛查呈阳性的人(FPP+/ID偏头痛+,n = 438)症状更严重,残疾程度更高,前额/眼部疼痛更频繁。FPP+/ID偏头痛-组(n = 48)的参与者更有可能报告鼻部症状、过敏和鼻窦感染,而FPP-/ID偏头痛+组(n = 85)的参与者报告的头痛致残性更强。
在这项探索性分析中,FPP与头痛(包括偏头痛)以及过敏、鼻窦炎和抗生素使用密切相关。抗生素报告的疗效较低表明可能存在误诊情况。偏头痛加上自主神经、前庭、耳部症状与FPP相关的发现,凸显了将鉴别诊断范围扩大到感染性病因之外的必要性。这些见解以及登记处的持续改进,将有助于提高神经科、耳科和鼻科疾病的诊断准确性并优化治疗策略。